Inactivation Of Cbl-b Can Obviate The Requirement For CD28 Costimulation Of T Cells In Tumor Rejection
Technology
E-153-2009
Patent ID
E-153-2009-0-US-04
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
9334522
Publication Number
US-2011-0287056-A1
Application Number
12/441,335
IC
NCI
Date Filed
Date Issued